Shenzhen Chipscreen Biosciences Co EBITDA
What is the EBITDA of Shenzhen Chipscreen Biosciences Co?
The EBITDA of Shenzhen Chipscreen Biosciences Co., Ltd. is ¥299.772k
What is the definition of EBITDA?
EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
ttm (trailing twelve months)
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA of companies in the Health Care sector on SSE compared to Shenzhen Chipscreen Biosciences Co
What does Shenzhen Chipscreen Biosciences Co do?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Companies with ebitda similar to Shenzhen Chipscreen Biosciences Co
- China Primary has EBITDA of HKD$292.000k
- Eurasia Fonciere Investissements Societe Anonyme has EBITDA of €293.667k
- O Sorbet D'amour SA has EBITDA of €295.051k
- hopTo has EBITDA of $297.400k
- Toyam Industries has EBITDA of ₨299.032k
- Strikewell has EBITDA of CAD$299.077k
- Shenzhen Chipscreen Biosciences Co has EBITDA of ¥299.772k
- Factor Therapeutics has EBITDA of AUD$300.274k
- Kesar Petroproducts has EBITDA of ₨302.000k
- RA International PLC has EBITDA of $302.000k
- BlueRock Diamonds PLC has EBITDA of £302.850k
- Zheng Li has EBITDA of SGD$303.000k
- First Responder Technologies has EBITDA of CAD$309.166k